Related Experiment Video
Updated: Jul 22, 2025

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Experimental pharmacology: Targeting metabolic pathways.
Vincenzo Leuzzi1, Serena Galosi1
1Department of Human Neuroscience, Sapienza University, Rome, Italy.
Metabolic treatments offer hope for inherited dystonias by targeting cell homeostasis. These approaches can prevent metabolite buildup and restore cell function, improving patient outcomes while gene therapy advances.
Area of Science:
- Neurology
- Genetics
- Metabolic Disorders
Background:
- Wilson disease treatment discovery spurred identification of other treatable inherited dystonias.
- Gene therapy for dystonia is progressing but not yet widely available.
- Understanding dystonia pathogenesis is crucial for developing effective treatments.
Purpose of the Study:
- To provide an update on current treatment strategies for inherited dystonias.
- To review genetic dystonias and emerging experimental therapies.
- To highlight the potential of metabolic approaches in managing dystonia.
Main Methods:
- Review of scientific literature on inherited dystonias and their treatments.
- Analysis of current and experimental therapeutic strategies.
- Focus on metabolic interventions targeting cell homeostasis.
Main Results:
- Several inherited dystonias are now treatable with specific metabolic interventions.
- Metabolic treatments can prevent neurotoxic metabolite accumulation and restore cell function.
- New experimental therapies are nearing clinical translation for genetic dystonias.
Conclusions:
- Metabolic treatments represent a significant advancement in managing inherited dystonias.
- Targeting metabolic derangements offers a viable therapeutic avenue for genetic dystonias.
- Continued research into pathogenesis and novel therapies is essential for improving patient care.
More Related Videos
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Regulation of Metabolism
Drug Discovery: Overview
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.